TRT for Muscle Gain: What to Realistically Expect

Medically reviewed by Katelyn Schwartz, NP, Family Nurse Practitioner with Advanced Training in TRT, BHRT, and Menopause Care
Last Reviewed: August 2026

Short answer: about a kilogram. In the longest placebo-controlled trial to measure body composition, older men with low or low-normal testosterone carried roughly 0.9 kg more lean mass than men on placebo after three years, with small gains in strength and power. The trial’s authors describe the change as small and say its clinical meaning is unclear. They also caution against applying it to men with diagnosed diseases of the testes, pituitary, or hypothalamus. Training and protein still do most of the work. TRT for muscle gain is not the reason the therapy exists.

Men rarely arrive at a clinic asking about lean mass first. They arrive because the last set feels heavier than it did two years ago. Recovery now takes four days instead of two. The training week that used to produce visible change produces nothing at all. Somewhere in that frustration, a search for TRT for muscle gain happens.

That search returns two very different worlds. One is a medical treatment for a measurable hormone deficiency. The other is a physique subculture running doses several times higher. Its risk profile has nothing to do with clinical care. Confusing the two is the single most common reason men come in with expectations no legitimate treatment can meet.

How Much Muscle Does Replacement-Dose Testosterone Actually Add?

What the longest trial measured

The clearest number comes from a three-year randomized trial by Storer and colleagues, published in the Journal of Clinical Endocrinology and Metabolism in 2017. It followed 256 community-dwelling men averaging 67 years of age, with total testosterone between 100 and 400 ng/dL. Each used a daily testosterone gel, with the dose adjusted to hold serum levels between 500 and 900 ng/dL.

Lean body mass differed by 0.9 kg between the treated and untreated groups. The 95% confidence interval ran from 0.5 to 1.4 kg. Chest-press strength differed by 16.3 newtons, which is roughly the force of pressing an extra 1.7 kg. Loaded stair-climbing power differed by 22.4 watts.

Those are real, statistically solid findings. The authors are blunt about their size, writing that the magnitude of change in muscle performance, physical function, and lean mass “was small, and the clinical meaningfulness of these changes remains unclear.”

The population behind the number

One detail decides how far the figure travels. The men in that trial were not classically hypogonadal, and the authors state directly that the findings “should not be extrapolated to hypogonadal men with known diseases of the testes, pituitary, or hypothalamus.”

So the kilogram belongs to older men with low or low-normal levels. Men with a pituitary or testicular diagnosis start from a different place, and the body-composition evidence in that group is thinner than the volume of online discussion suggests. Naming that gap is more useful than papering over it.

Why that number looks small next to gym claims

Most of the disappointment around TRT for muscle gain starts here. A kilogram of lean tissue distributed across a whole body is not a visible transformation. That much lean muscle mass shows up as a slightly fuller arm, a slightly better third set, and a recovery window that closes a little faster than it used to.

Men who expect a mirror change in twelve weeks are usually comparing a medical dose against numbers generated at doses no Canadian clinician prescribes. A replacement dose and a physique dose are separated by a factor of several, and that gap is where the expectation breaks.

Where the extra tissue comes from

Testosterone binds androgen receptors in skeletal muscle, and that binding increases both the recruitment of satellite cells and the number of myonuclei available to a working muscle fiber. More myonuclei means more capacity for protein synthesis, so each training stimulus is met with a slightly larger repair response.

The hormone also raises red blood cell production, which is one reason a rising hematocrit is among the first things a clinician watches for. That effect is monitored as a risk rather than counted as a performance benefit.

None of this bypasses the training itself. Androgen receptors respond to a stimulus; without the stimulus, there is far less to amplify. You can read more on the interaction in our guide to the relationship between TRT and exercise.

Testosterone Replacement Therapy for Muscle Gain

TRT and Steroid Cycles Are Not the Same Intervention

Dose is the dividing line

A 2001 dose-response study in healthy young men, published in the American Journal of Physiology, makes the distinction impossible to miss. Sixty-one healthy young participants received weekly testosterone injections ranging from 25 mg up to 600 mg for 20 weeks, with their own hormone production suppressed for the duration so that the assigned dose was the only source.

Fat-free mass rose in step with the dose: about 3.4 kg at 125 mg weekly, 5.2 kg at 300 mg, and 7.9 kg at 600 mg. Replacement therapy aims at a normal physiological level. That target sits far below the upper end of the range tested.

The lowest of those three doses sits within the range a clinician might use. The 300 mg and 600 mg arms do not, and they are where the dramatic figures circulating online come from.

The famous 1996 figures came from six times a replacement dose

The study most often quoted in muscle-building discussions is a 1996 New England Journal of Medicine trial. Forty men completed it across four groups: testosterone or placebo, each with or without supervised strength training. The testosterone dose was 600 mg weekly for ten weeks, roughly six times a replacement dose.

Fat-free mass rose 3.2 kg with testosterone and no training. Training without testosterone produced 1.9 kg, while the two together produced 6.1 kg. Bench-press strength rose by 22 kg in the combined group, against 9 kg with testosterone alone and 1 kg on placebo. Those figures are frequently repackaged as what TRT does, which misrepresents the dose several times over.

What high-dose use does to the heart

A 2025 narrative review in Biomedicines by Iliakis and colleagues gathers the imaging evidence on long-term anabolic-androgenic steroid use. It reports increased left ventricular mass, thicker ventricular walls, and both systolic and diastolic dysfunction. In one imaging cohort, 71 percent of current users had ejection fractions below the normal threshold of 52 percent.

It is a narrative review rather than a pooled analysis. Read it as a consistent signal, not a precise risk estimate. The review is explicit that these doses run “significantly higher than those used in clinical practice.”

That contrast is the whole point. Supervised replacement and unsupervised high-dose use share a molecule and almost nothing else. Our explainer on whether TRT therapy is considered a steroid covers the terminology. TRT myths versus facts addresses the claims that circulate alongside it.

Who Actually Qualifies for Treatment

What a diagnosis requires

Wanting more muscle is not a diagnosis, and no responsible Canadian prescriber treats it as one.

The Endocrine Society issued a statement on 16 July 2026 restating what a diagnosis requires. Symptoms of low testosterone must sit alongside consistently low, accurately measured total and free testosterone. In practice that means at least two early-morning fasting blood tests, using certified assays, with a common clinical threshold near 300 ng/dL. The Canadian Urological Association guideline sets a comparable line, describing a total testosterone below 10 nmol/L as a reasonable diagnostic threshold.

Read more about TRT Blood Test: Your Guide to Safe Treatment.

Where weight comes first

Two further points from that statement matter for anyone searching on this topic. There is insufficient evidence to support population-level screening of men who have no symptoms, so a test ordered out of curiosity rarely leads anywhere useful. For men carrying excess weight, with a BMI above 27 and no other identified cause, weight loss is typically first-line therapy.

Where to start if you are unsure

If weight is the primary concern, our article on losing weight with TRT sets out what the trials found.
If the question is whether your symptoms warrant testing, start with which doctor can help with low testosterone.
The difference between total and free testosterone explains what the lab report is telling you.
The clinical picture behind a prescription is covered in reasons doctors prescribe TRT therapy.

Testosterone or Training: Which One Moves the Needle?

Reading the comparison correctly

The honest comparison is uncomfortable for anyone hoping the injection is the shortcut.

Rows below are not directly comparable, and the difference matters. The training figure, drawn from a meta-analysis by Peterson and colleagues and summarized in the 2024 Sports Medicine – Open review, is a pooled within-group change, as are the 1996 figures. The three-year figure is the difference between a treated group and a placebo group, which is a stricter measure. Populations differ too, from healthy young men to men in their sixties.

Approach	Change in lean mass	Population and duration
Resistance training	+1.1 kg	Meta-analysis of 49 studies in adults over 50, average 20.5 weeks
Replacement-dose testosterone versus placebo	+0.9 kg	256 men, average age 67, low or low-normal levels, three years
High-dose testosterone, no training	+3.2 kg	600 mg weekly, healthy young men, ten weeks
High-dose testosterone plus training	+6.1 kg	600 mg weekly, healthy young men, ten weeks

What the 2024 review concluded

A 2024 review in Sports Medicine-Open compared these two levers directly across the aging-male literature. For strength, its conclusion was that an exercise programme is likely to be more beneficial than testosterone treatment, and that adding testosterone at physiological concentrations does not provide further benefit beyond exercise alone. For lean body mass, the review is more open, noting that both improve it and that the combination may be more beneficial than either in isolation.

Read that carefully, because it is not an argument against treatment. It is an argument against expecting treatment to replace training. For men already training, the role of strength training shapes results more than the prescription does. So does the balance between cardio and strength work.

A Realistic Timeline

Period	What guidance and trials describe
First 6 to 8 weeks	Levels stabilise, first bloodwork repeat, no body composition change expected
Around 3 months	Symptom review; energy and mood changes are commonly reported, though poorly quantified in trials
From 6 months	Canadian guidance notes that structural changes, including muscle mass and bone density, may take upwards of six months
3 years	The measured difference between treated and untreated men was still about a kilogram at the trial endpoint

The last row is the one most often missed. At three years, the gap between treated and untreated men was still about a kilogram, so nothing in the data suggests it compounds year on year. Anyone describing year-on-year accumulation from the therapy alone is describing something the trials did not find.

How long treatment continues is a separate clinical decision, covered in how long you should be on testosterone replacement therapy.

For the symptom side of the timeline, see effects of testosterone replacement therapy.

What Treatment Will Not Do for Your Physique

Five expectations account for most of the frustration men bring back at the three-month review.

It will not replace the stimulus. The largest gains in every trial came from the arm that combined testosterone with training, not from the hormone alone.
It is not indicated for a man whose levels are normal. No guideline supports treating a normal result, and screening men without symptoms is explicitly not recommended.
It will not deliver a visible transformation on its own. A kilogram spread across the whole body reads on a scan, not in a photograph.
It will not protect fertility. Suppression of sperm production is an expected effect, so restoring fertility after treatment is a conversation for before you start rather than after.
It will not compensate for four hours of sleep or a protein intake built on guesswork. Both levers are free, and both are covered in our guides to sleep and protein intake.

Risks Worth Weighing Before You Start

Cardiovascular outcomes

The TRAVERSE trial was published in the New England Journal of Medicine in 2023. It enrolled 5,246 men aged 45 to 80 with existing or high cardiovascular risk. All had two fasting testosterone readings below 300 ng/dL.

A primary cardiovascular event occurred in 182 men (7.0 percent) on testosterone and 190 men (7.3 percent) on placebo. The hazard ratio was 0.96, with a confidence interval of 0.78 to 1.17. That is reassuring on the headline question.

The secondary findings are less quiet. Atrial fibrillation occurred in 3.5 percent of treated men, against 2.4 percent on placebo. Acute kidney injury ran 2.3 versus 1.5 percent, and pulmonary embolism 0.9 versus 0.5 percent.

Bone and fracture

A fracture substudy of the same trial, reported in the New England Journal of Medicine in 2024, followed 5,204 men for a median of 3.19 years. Clinical fractures occurred in 3.50 percent of the testosterone group and 2.46 percent of the placebo group. The hazard ratio was 1.43, with a confidence interval of 1.04 to 1.97.

Testosterone therapy did not reduce fractures. So, anyone told that treatment strengthens the skeleton should see that result first.

Blood thickening, prostate, and sleep

Rising hematocrit is the most common reason a dose is reduced or paused. In TRAVERSE, dosing was adjusted whenever hematocrit passed 54 percent. Treatment stopped if it stayed above that on the lowest dose.

Prostate monitoring and sleep-disordered breathing both belong in the same conversation. Four related guides cover them:

prostate cancer concerns and TRT
TRT and enlarged prostate
testosterone therapy and sleep apnea
stroke risk

For day-to-day management, see navigating potential side effects.

Getting the Most Out of Treatment

Train the pattern, not the muscle. Compound lifts across two to four sessions weekly give the hormone something to act on.
Eat enough protein consistently. Under-eating protein is the most common reason a treated man sees nothing on a scan.
Protect sleep. Recovery is where repair happens, and short sleep undercuts both the training and the therapy.
Give it two review cycles. Body composition change trails symptom change by months.
Keep the bloodwork appointments. Monitoring is what separates supervised treatment from the alternative.

Canadian guidance asks clinicians to track hematocrit for polycythemia and to monitor prostate health with PSA testing, alongside repeat hormone levels. Delivery method affects how steady those levels stay between appointments, which is set out in TRT methods and approaches.

Considering TRT in Canada

Men who do best with TRT for muscle gain tend to be the ones who came in for symptoms and stayed for the training. Fatigue, low mood, poor recovery and reduced libido are what treatment is actually for, and the change in body composition follows the work you put in around it.

If that describes your situation, the starting point is a proper diagnosis rather than a protocol. Our testosterone replacement therapy service page explains how assessment, lab work and monitoring fit together. In British Columbia, the TRT in Vancouver program runs the full pathway, and you can check your eligibility and book a consultation there.

TRT for Muscle Gain: Common Questions

Q: How much muscle can I realistically expect to gain on TRT?

In a three-year randomised trial of men averaging 67 years with low or low-normal testosterone, the treated group carried about 0.9 kg more lean mass than the placebo group. Gains in chest-press strength and stair-climbing power were small but measurable, and the trial’s authors describe the clinical meaning of that size of change as unclear. Men who train consistently give the therapy more to work with. Nobody should plan around a figure larger than a few kilograms.

Q: Is TRT for muscle gain legal in Canada?

Testosterone is a prescription therapy in Canada, prescribed for a diagnosed deficiency confirmed by symptoms and repeated morning blood tests. Prescribing it to a man with normal levels for physique reasons falls outside guideline practice. The Endocrine Society statement of July 2026 is explicit that diagnosis, not preference, sets the threshold.

Q: Will TRT build muscle if my testosterone is already normal?

There is no guideline support for treating a normal result, and screening men without symptoms is specifically not recommended. Men in that position have no clinical indication for treatment, and a structured training block, a protein audit, and better sleep are the levers that remain.

Q: How long before I notice a difference in the gym?

Canadian guidance describes structural changes, including muscle mass, as taking upwards of six months. Energy and recovery often shift earlier, though those reports are not well quantified in trials. Judging results at eight weeks is judging the wrong window.

Q: Is TRT the same as taking steroids?

The molecule overlaps; the dose, the supervision and the risk profile do not. Replacement restores a physiological level under monitoring, whereas high-dose use runs several times higher and is associated with structural heart changes in long-term users.

Do I lose the gains if I stop treatment?

Levels return toward their untreated baseline once therapy ends, and the small composition advantage tends to fade with them. That is truer still if training stops at the same time. Stopping is a clinical decision with its own timeline, so how long you should stay on treatment is worth discussing before you start.

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment. Individual results depend on baseline hormone levels, health status, training history, and lifestyle factors.